Who owns SPRUCE BIOSCIENCES INC?
- Ticker: SPRB
- CUSIP Number: 85209e208
Tip: Access positions for across all investors
Analyze quarterly positions in Spruce Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Spruce Biosciences stock
Who bought or sold SPRUCE BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 121k | $7.9M | 0% | Mar 2026 |
|
| Millennium Management | 112k | $7.3M | 100% | Mar 2026 |
|
| Citadel Advisors | 70k | $4.6M | 0% | Mar 2026 |
|
| Wellington Management Company | 59k | $5.1M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 59k | $3.8M | 1% | Mar 2026 |
|
| Alyeska Investment Group | 52k | $3.4M | 0% | Mar 2026 |
|
| Boothbay Fund Management | 42k | $2.7M | -12% | Mar 2026 |
|
| Balyasny Asset Management | 40k | $2.6M | 0% | Mar 2026 |
|
| Carlyle | 39k | $2.5M | 0% | Mar 2026 |
|
| Quinn Opportunity Partners | 23k | $2.0M | 100% | Dec 2025 |
|
| Caligan Partners | 21k | $1.8M | 100% | Dec 2025 |
|
| Stonepine Capital Management | 20k | $1.7M | 100% | Dec 2025 |
|
| Vanguard Group | 18k | $1.6M | 100% | Dec 2025 |
|
| BlackRock | 17k | $1.1M | 0% | Mar 2026 |
|
| Geode Capital Management | 13k | $843k | 1% | Mar 2026 |
|
| Squadron Capital Management | 12k | $797k | 100% | Mar 2026 |
|
| Superstring Capital Management | 12k | $1.1M | 100% | Dec 2025 |
|
| State Street Corporation | 6.4k | $558k | 100% | Dec 2025 |
|
| Stempoint Capital | 6.4k | $416k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 5.5k | $360k | 100% | Mar 2026 |
|
| Goldman Sachs Group | 5.5k | $360k | 100% | Mar 2026 |
|
| Resolute Capital Asset Partners | 4.0k | $261k | 0% | Mar 2026 |
|
| UBS Group | 3.9k | $256k | -20% | Mar 2026 |
|
| SkyView Investment Advisors | 3.0k | $261k | 100% | Dec 2025 |
|
| Persistent Asset Partners | 2.5k | $165k | 100% | Mar 2026 |
|
| Northern Trust | 2.4k | $211k | 100% | Dec 2025 |
|
| Morgan Stanley | 1.4k | $93k | 265% | Mar 2026 |
|
| Lion Point Capital | 1.0k | $65k | 0% | Mar 2026 |
|
| Citigroup | 939.00 | $61k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 452.00 | $30k | 100% | Mar 2026 |
|
| Sound Income Strategies | 200.00 | $14k | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 84.00 | $7.3k | 100% | Dec 2025 |
|
| Caldwell Sutter Capital | 13.00 | $849.999800 | 0% | Mar 2026 |
|
| Cassaday & Co Wealth Management | 2.00 | $130.000000 | 100% | Mar 2026 |
|
| Tower Research Capital | 1.00 | $87.000000 | 100% | Dec 2025 |
|
Who sold out of Spruce Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| ExodusPoint Capital Management | Dec 2025 | 25k | $2.2M |
| Schonfeld Strategic Advisors | Dec 2025 | 25k | $2.2M |
| Bnp Paribas Arbitrage, Snc | Dec 2025 | 2.0k | $174k |
| Advisor Group Holdings | Sep 2025 | 133.00 | $931.000000 |